Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard have developed a novel biomimetic strategy that delivers life-saving nanotherapeutics directly to obstructed blood vessels, dissolving blood clots before they cause serious damage or even death. The research was led by Wyss Director Donald Ingber, Judah Folkman Professor of Vascular Biology at HMS, and Wyss Technology Development Fellow Netanel Korin.
